This company listing is no longer active
Pfizer Resultados de beneficios anteriores
Pasado controles de criterios 6/6
Información clave
11.1%
Tasa de crecimiento de los beneficios
12.8%
Tasa de crecimiento del BPA
Crecimiento de la industria Pharmaceuticals | 30.5% |
Tasa de crecimiento de los ingresos | 16.3% |
Rentabilidad financiera | 32.7% |
Margen neto | 31.3% |
Última actualización de beneficios | 31 Dec 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Pfizer. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
31 Dec 22 | 100,330 | 31,366 | 12,200 | 11,428 |
02 Oct 22 | 99,878 | 29,953 | 11,327 | 11,417 |
03 Jul 22 | 101,275 | 29,481 | 10,038 | 11,400 |
03 Apr 22 | 92,433 | 25,410 | 9,404 | 10,824 |
31 Dec 21 | 81,288 | 22,413 | 9,562 | 10,360 |
03 Oct 21 | 68,877 | 19,485 | 9,714 | 9,972 |
04 Jul 21 | 55,119 | 12,236 | 11,676 | 9,589 |
04 Apr 21 | 46,084 | 9,032 | 11,454 | 9,184 |
31 Dec 20 | 41,651 | 6,630 | 11,418 | 8,709 |
27 Sep 20 | 32,334 | 212 | 11,006 | 8,084 |
28 Jun 20 | 34,737 | 6,977 | 10,565 | 7,727 |
29 Mar 20 | 38,137 | 9,427 | 11,637 | 7,716 |
31 Dec 19 | 40,905 | 10,707 | 12,766 | 7,721 |
29 Sep 19 | 53,039 | 16,211 | 13,755 | 7,891 |
30 Jun 19 | 53,656 | 12,638 | 14,050 | 7,948 |
31 Mar 19 | 53,859 | 11,464 | 14,004 | 7,914 |
31 Dec 18 | 40,825 | 3,824 | 12,149 | 7,713 |
30 Sep 18 | 53,373 | 23,808 | 14,481 | 7,827 |
01 Jul 18 | 53,244 | 22,545 | 14,492 | 7,686 |
01 Apr 18 | 52,673 | 21,746 | 14,509 | 7,673 |
31 Dec 17 | 52,546 | 21,305 | 14,606 | 7,645 |
01 Oct 17 | 52,471 | 9,791 | 14,546 | 7,843 |
02 Jul 17 | 52,347 | 8,308 | 14,608 | 7,861 |
02 Apr 17 | 52,598 | 7,281 | 14,959 | 7,826 |
31 Dec 16 | 52,824 | 7,198 | 14,894 | 7,858 |
02 Oct 16 | 53,243 | 6,270 | 14,956 | 7,652 |
03 Jul 16 | 52,286 | 7,036 | 14,697 | 7,797 |
03 Apr 16 | 50,992 | 7,615 | 14,339 | 7,787 |
Ingresos de calidad: PFE has high quality earnings.
Margen de beneficios creciente: PFE's current net profit margins (31.3%) are higher than last year (27.6%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: PFE's earnings have grown by 11.1% per year over the past 5 years.
Acelerando crecimiento: PFE's earnings growth over the past year (39.9%) exceeds its 5-year average (11.1% per year).
Beneficios vs. Industria: PFE earnings growth over the past year (39.9%) exceeded the Pharmaceuticals industry 21.1%.
Rentabilidad financiera
Alta ROE: PFE's Return on Equity (32.7%) is considered high.